The Korean Journal of Nuclear Medicine (대한핵의학회지)

The Korean Society of Nuclear Medicine (대한핵의학회)
권호 표지

Evaluation of Liver Function Using $^{99m}-Lactosylated$ Serum Albumin Liver Scintigraphy in Rat with Acute Hepatic Injury Induced by Dimethylnitrosamine

Dimethylnitrosamine 유발 급성 간 손상 흰쥐에서 $^{99m}-Lactosylated$ Serum Albumin을 이용한 간 기능의 평가

  • Jeong, Shin-Young (Department of Nuclear Medicine, Kyungpook National University School of Medicine) ;
  • Seo, Myung-Rang (Department of Nuclear Medicine, Kyungpook National University School of Medicine) ;
  • Yoo, Jeong-Ah (Department of Nuclear Medicine, Kyungpook National University School of Medicine) ;
  • Bae, Jin-Ho (Department of Nuclear Medicine, Kyungpook National University School of Medicine) ;
  • Ahn, Byeong-Cheol (Department of Nuclear Medicine, Kyungpook National University School of Medicine) ;
  • Hwang, Jae-Seok (Department of Nuclear Medicine, Kyungpook National University School of Medicine) ;
  • Jeong, Jae-Min (Department of Nuclear Medicine, Seoul National Univeristy School of Medicine) ;
  • Ha, Jeong-Hee (Department of Pharmacology, Youngnam Univeristy School of Medicine) ;
  • Lee, Kyu-Bo (Department of Nuclear Medicine, Kyungpook National University School of Medicine) ;
  • Lee, Jae-Tae (Department of Nuclear Medicine, Kyungpook National University School of Medicine)
  • 정신영 (경북대학교 의과대학 핵의학교실) ;
  • 서명랑 (경북대학교 의과대학 핵의학교실) ;
  • 유정아 (경북대학교 의과대학 핵의학교실) ;
  • 배진호 (경북대학교 의과대학 핵의학교실) ;
  • 안병철 (경북대학교 의과대학 핵의학교실) ;
  • 황재석 (경북대학교 의과대학 핵의학교실) ;
  • 정재민 (서울대학교 의과대학 핵의학교실) ;
  • 하정희 (영남대학교 의과대학 약리학교실) ;
  • 이규보 (경북대학교 의과대학 핵의학교실) ;
  • 이재태 (경북대학교 의과대학 핵의학교실)
  • Published : 2003.12.30
Download PDF
⟨ Previous Next ⟩

Abstract

Objects: $^{99m}-lactosylated$ human serum albumin (LSA) is a newly synthesized radiopharmaceutical that binds to asialoglycoprotein receptors, which are specifically presented on the hepatocyte membrane. Hepatic uptake and blood clearance of LSA were evaluated in rat with acute hepatic injury induced by dimethylnitrosamine (DMN) and results were compared with corresponding findings of liver enzyme profile and these of histologic changes. Materials and Methods: DMN (27 mg/kg) was injected intraperitoneally in Sprague-Dawley rat to induce acute hepatic injury. At 3(DMN-3), 8(DMN-8), and 21 (DMN-21) days after injection of DMN, LSA injected intravenously, and dynamic images of the liver and heart were recorded for 30 minutes. Time-activity curves of the heart and liver were generated from regions of interest drawn over liver and heart area. Degree of hepatic uptake and blood clearance of LSA were evaluated with visual interpretation and semiquantitative analysis using parameters (receptor index : LHL3 and index of blood clearance : HH3), analysis of time-activity curve was also performed with curve fitting using Prism program. Results: Visual assessment of LSA images revealed decreased hepatic uptake in DMN treated rat, compared to control group. In semiquantitative analysis, LHL3 was significantly lower in DMN treated rat group than control rat group (DMN-3: 0.842, DMN-8: 0.898, DMN-21: 0.91, Control: 0.96, p<0.05), whereas HH3 was significantly higher than control rat group (DMN-3: 0.731,.DMN-8: 0.654, DMN-21: 0.604, Control: 0.473, p<0.05). AST and ALT were significantly higher in DMN-3 group than those of control group. Centrilobular necrosis and infiltration of inflammatory cells were most prominent in DMN-3 group, and were decreased over time. Conclusion: The degree of hepatic uptake of LSA was inversely correlated with liver transaminase and degree of histologic liver injury in rat with acute hepatic injury.

목적: $^{99m}-lactosylated$ serum albumin ($^{99m}Tc-LSA$)은 간세포에 특이적으로 결합하는 간수용체 영상용 방사성의약품으로 새로이 합성되었다. 간섬유화를 유발하는 dimethylnitrosamine (DMN)을 투여한 간 손상 흰쥐 모델에서 $^{99m}Tc-LSA$의 역동학적인 간섭취를 조사하고 간효소치의 변화와 조직학적 소견을 비교하여, LSA의 간섭취가 간기능의 변화를 반영하는지를 연구하였다. 대상 및 방법: SD계 흰쥐에 DMN를 27 mg/kg으로 복강 내 주사하여 급성 간손상을 유도하고 대조군과 비교하였다. DMN을 주사한 흰쥐를 3일(DMN-3), 8일(DMN-8), 21일(DMN-21)에 $^{99m}Tc-LSA$ (1,665 mg/kg) 29 MBq를 정맥 주사하여, 30분 동안 동적 영상을 획득하고 간과 심장부위에 관심영역을 설정하여 간과 심장부위의 시간방사능 곡선을 얻었다. 간기능 평가를 위해 시간방사능 곡선을 이용하여 간섭취지수와 혈중제거지수를 구하였고 곡선 최적화를 시행하였다. DMN 투여군과 대조군의 간효소치의 변화와 간조직의 광학현미경 소견을 비교하였다. 결과: 대조군에서는 $^{99m}Tc-LSA$가 빠르게 간에 섭취되고 혈중에서 제거되었으나 DMN을 처리한 군에서는 간섭취가 낮았다. 간섭취지수의 비교에서 대조군에 비해 DMN 처리군에서 유의하게 간섭취지수가 낮았다(DMN-3: 0.842, BMN-8: 0.898, DMN-21: 0.91, 대조군: 0.96, p<0.05). 혈중제거지수의 비교에서도 대조군에 비해 DMN 처리군에서 혈중제거지수가 유의하게 높았다(DMN-3: 0.731, DMN-8: 0.654, DMN-21: 0.604, 대조군: 0.473, p<0.05). 비선형 회귀분석에서 $R_2$값은 0.9이상으로 좋은 일치를 보였고, 대조군에서 K값이 DMN처리군에 비해 크고 (DMN-3: 0.28, DMN-8: 0.41, DMN-21: 0.46, 대조군: 0.97, p<0.05), $T_{1/2}$값은 작았다(DMN-3: 2.5, DMN-8: 1.7, DMN-21: 1.5, 대조군: 0.7, p<0.05). 간효소치의 변화는 DMN-3군에서는 대조군에 비해 상승하였으나 DMN-8, DMN-21군에서는 간효소치의 상승이 관찰되지 않았다. 간조직 소견의 경우 DMN-3군에서 중심정맥 주위에 괴사가 관찰되었으나 DMN-8군, DMN-21군에서는 미약한 정도의 염증세포 침윤만이 관찰되었다. 결론: $^{99m}Tc-LSA$ 간신티그래피의 간섭취 정도는 간손상과 반비례하였으며 간섭취의 변화는 조직학적 손상이 심한 정도와 간손상후 회복되는 과정을 반영하여 주었다. $^{99m}Tc-LSA$ 간신티그래피가 간손상을 평가하고 간손상후 회복되는 과정을 추적하는 간수용체 영상용 방사성 의약품으로 사용될 수 있을 것으로 생각된다.

Keywords

References

  1. Gelfand MJ, Saha S, Aron BS. Imaging of irradiated liver with $^99m$Tc-sulfur colloid and $^99m$Tc-IDA. Clin Nucl Med 1981;6:399-402 https://doi.org/10.1097/00003072-198109000-00003
  2. Brunot B, Petras S, Germain P, Vinee P, Constantinesco A. Biopsy and quantitative hepatobiliary scintigraphy in the evaluation of liver transplantation. J Nucl Med 1994;35:321-7
  3. Pimostone NR, Standalnik RC, Vera DR, Hutak DP, Trudeau WL. Evaluation of hepatocelluar function by way of receptor-mediated uptake of a technetium-99m-labeled asialoglycopretein analog. Hepatol 1994;20:917-23 https://doi.org/10.1002/hep.1840200421
  4. Tomiguchi S, Kira T, Oyama Y, Nabeshima M, Nakashima R, Tsuji A, et al. Correlation of Tc-99m GSA hepatic studies with biopsies in patients with chronic active hepatitis. Clin Nucl Med 1995;20:717-20 https://doi.org/10.1097/00003072-199508000-00013
  5. Kubota Y, Kitagawa S, Inoue K, Ha-Kawa SK, Kojima M, Tanaka Y. Hepatic functional scintigraphic imaging with $^99m$Tc-galactosyl serum albumin. Hepatogastroenterology 1993;40:32-6
  6. Huheey JE. Acid-Base Chemistry. In: Wasserman M, editor. Inorganic Chemistry: Principle of Structure and Reactivity. 3rd ed. New York: Harper & Row Publishers, Inc; 1996. p. 286-327
  7. Rearden DT, Meares CF, Goodwin DA, McTigue M, David GS, Stone MR, et al. Antibodies against metal chelates. Nature 1985;316:265-7 https://doi.org/10.1038/316265a0
  8. DeNardo GL, Mirick GR, Kroger LA, O`Donnell RT, Meares CF, DeNardo SJ. Antibodies responses to macrocycles in lymphoma. J Nucl Med 1996;37:451-6
  9. Jeong JM, Hong MK, Lee J, Son MW, So Y, Lee DS, et al. Tc-99m Neolactosylated human serum albumin (LSA) for imaging the hepatic asialoglycoprotein receptor. Nucl Med Biol. In press, 2003
  10. Mather, SJ, Ellison, E. Reduction-mediated technetium-99m labeling of monoclonal antibodies. J Nucl Med 1990;31:692-7
  11. Sasaki N, Shiomi S, Iwata Y, Nishiguchi S, Kuroki T, Kawabe J, et al. Clinical usefulness of scintigraphy with $^99m$Tc-galactosyl-human serum albumin for prognosis of cirrhosis of the liver. J Nucl Med 1999;40:1652-6
  12. Lee J. Quantitative evaluation of liver function with hepatic receptor scintigraphy using Tc-99m galactosylated serum albumin (GSA). Korea J Nucl Med 1998;32:305-13
  13. Ha-Kawa SK, Tanaka Y, Hasebe S, Kuniyasu Y, Koizumi K, Ishii Y, et al. Compartmental analysis of asialoglycoprotein receptor scintigraphy for quantitative measurement of liver function: a multicenter study. Eur J Nucl Med 1997;24:130-7 https://doi.org/10.1007/BF02439544
  14. Imaeda T, Kanematsu M, Asada S, Seki M, Doi H, Saji S, et al. Utility of Tc-99m GSA SPECT imaging in estimation of functional volume of liver segments in health and liver disease. Clin Nucl Med 1995;20:322-8 https://doi.org/10.1097/00003072-199504000-00008
  15. Sakahara H, Kiuchi T, Nishizawa S, Saga T, Nakamoto Y, Sato N, et al. Asialoglycoprotein receptor scintigraphy in evaluation of auxiliary partial orthotopic liver transplantation. J Nucl Med 1999;40:1463-7
  16. Kudo M, Todo A, Ikekubo K, Hino M. Receptor index via hepatic asialoglycoprotein receptor imaging: correlation with chronic hepatocellular damage. Am J Gastroenterol 1992;87:865-70
  17. Kubota Y, Kitagawa S, Inoue K, Ha-Kawa SK, Kojima M, Tanaka Y. Hepatic functional scintigraphic imaging with $^99m$Tc-galactosyl serum albumin. Hepatogastroenterology 1993;40:32-6
  18. Hyun DW, Lee J, Chun KA, Lee SW, Kim SK, Kang DY, et al. Hepatic asialoglycoprotein receptor scintigraphy using $^99m$Tc-galactosylated serum albumin (GSA): biodistribution study in mice with thioacetamide-induced hepatic injury. Korea J Hepatol 1998;4:151-61
  19. Shiomi S, Kuroki T, Enomoto M, Ueda T, Masaki K, Ikeoka N, et al. Fulminant hepatic failure monitored by technetium-99m-DTPA-galactosyl -human serum albumin scintigraphy. J Nucl Med 1996;37:641-3
  20. Hwang EH, Taki J, Shuke N, Nakajima S, Kinuya S, Konishi S, et al. Preoperative assessment of residual hepatic functional reserve using $^99m$Tc-DTPA-galactosyl-human serum albumin dynamic SPECT. J Nucl Med 1999;40:1644-51
  21. Sueyoshi K, Narabayashi I, Aratani T, Doi K, Komori T, Ogura Y, et al. Utility of Tc-99m GSA whole-body scintigraphy in detection bone metastasis from hepatocelluar carcinoma. Clin Nucl Med 2001;26:221-4 https://doi.org/10.1097/00003072-200103000-00008
  22. Craddock VM. Nitrosamines and human cancer: proof of an association? Nature 1983;306:638
  23. Montesano R, Bartsch H. Mutagenic and carcinogenic N-nitroso compounds: possible environmental hazards. Mutat Res 1976;32:179-228 https://doi.org/10.1016/0165-1110(76)90001-4
  24. Mayer MJ, Schook LB. Immunotoxicity of nitrosamines. In: Smialowicz RJ, Holsapple MP, editors. Experimental Immunotoxicology CRC Press, Boca Raton;1996, p. 351-66